Terbutaline enhances autophagy initiation without restoring autophagic flux in RAW 264.7 macrophages during hypervirulent Klebsiella pneumoniae infection
Hypervirulent Klebsiella pneumoniae (hvKP) can cause pyogenic liver abscesses and metastatic infections. Macrophage autophagy contributes to host defense, but its antibacterial effects depend on effective autophagic processing. The β2-adrenergic receptor (β2-AR) has been implicated in autophagy regulation, yet the effects of its agonists during hvKP infection remain unclear. We investigated the effects of the β2-AR agonist terbutaline (Ter) on autophagy and host responses in hvKP-infected RAW 264.7 macrophages. hvKP infection upregulated β2-AR expression and induced an early autophagic response followed by impaired autophagic flux. Ter increased LC3-II, Beclin-1, and LAMP2 levels and enhanced AMPKα and ULK1 phosphorylation. Compound C attenuated the Ter-associated increases in ULK1 phosphorylation, LC3-II, and Beclin-1, suggesting a contribution of AMPK/ULK1 signaling. However, chloroquine treatment and tandem LC3B reporter analysis showed no detectable restoration of autophagic flux by Ter during infection. Ter also increased recoverable intracellular bacterial counts and bacterial 16S rDNA abundance. In parallel, Ter enhanced Il1b and Il6 expression and NF-κB p65 phosphorylation, while reducing ROS-associated fluorescence and improving cell viability. These findings indicate that Ter enhances autophagy initiation without restoring autophagic flux in hvKP-infected RAW 264.7 macrophages, accompanied by increased intracellular bacterial burden and altered inflammatory and oxidative responses. Enhanced autophagy initiation therefore does not necessarily translate into improved antibacterial defense in this infection model.
Authors
- Lixiu Huang
- Jinli Bi
- Minqing Wu
- Xuyang Li
- Taijie Li
- Anli Lu
- Zhenhong Su
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fimmu.2026.2005956
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- National Natural Science Foundation of China